Gene expression analysis reveals evidence for inactivation of the TGF-β signaling cascade in autonomously functioning thyroid nodules

Oncogene

Volumn 23, Issue 3, 2004, Pages 795-804

  Eszlinger, Markus ^a   Krohn, Knut ^a,b   Frenzel, Romy ^a   Kropf, Siegfried ^c   Tönjes, Anke ^a   Paschke, Ralf ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Sialyltransferase 1; Signal transduction; Thyroid; Transforming growth factor beta 1; TSH receptor

Indexed keywords

5 IODOTHYRONINE DEIODINASE 1; IODIDE PEROXIDASE; SIALYLTRANSFERASE; SIALYLTRANSFERASE 1; THYROID PEROXIDASE; THYROTROPIN RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL SURFACE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; HORMONE BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; THYROID NODULE; UPREGULATION;

ANIMALS; COS CELLS; GENE EXPRESSION PROFILING; HUMANS; SIGNAL TRANSDUCTION; THYROID NODULE; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA;

EID: 1242317868     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207186     Document Type: Article

References (42)

1. Arturi F, Capula C, Chiefari E, Filetti S and Russo D. (1998). Exp. Clin. Endocrinol. Diabetes, 106, 234-236.
2. Biebermann H, Schoneberg T, Schulz A, Krause G, Gruters A, Schultz G and Gudermann T. (1998). FASEB J., 12, 1461-1471.
3. Colletta G, Cirafici AM and Di Carlo A. (1989). Cancer Res., 49, 3457-3462.
4. Coyle P, Philcox JC, Carey LC and Rofe AM. (2002). Cell Mol. Life Sci., 59, 627-647.
5. Dahlquist KD, Salomonis N, Vranizan K, Lawlor SC and Conklin BR. (2002). Nat. Genet., 31, 19-20.
6. Depoortere F, Pirson I, Bartek J, Dumont JE and Roger PP. (2000). Mol. Biol. Cell, 11, 1061-1076.
7. Eisen MB, Spellman PT, Brown PO and Botstein D. (1998). Proc. Natl. Acad. Sci. USA, 95, 14863-14868.
8. Eszlinger M, Krohn K, Kratzsch J, Voigt C and Paschke R. (2001a). Thyroid, 11, 125-135.
9. Eszlinger M, Krohn K and Paschke R. (2001b). J. Clin. Endocrinol. Metab., 86, 4834-4842.
10. Fuhrer D, Mix M, Wonerow P, Richter I, Willgerodt H and Paschke R. (1999). Thyroid, 9, 757-761.
11. Gärtner R, Schopohl D, Schaefer S, Dugrillon A, Erdmann A, Toda S and Bechtner G. (1997). Thyroid, 7, 633-640.
12. Grande M, Franzen A, Karlsson JO, Ericson LE, Heldin NE and Nilsson M. (2002). J. Cell Sci., 115, 4227-4236.
13. Grubeck-Loebenstein B, Buchan G, Sadeghi R, Kissonerghis M, Londei M, Turner M, Pirich K, Roka R, Niederle B and Kassal H. (1989). J. Clin. Invest., 83, 764-770.
14. Hedinger C. (1988). Histological Typing of Thyroid Tumors. Springer Verlag: Berlin/Heidelberg/New York.
15. Huang Y, Prasad M, Lemon WJ, Hampel H, Wright FA, Kornacker K, LiVolsi V, Frankel W, Kloos RT, Eng C, Pellegata NS and de la Chapelle A. (2001). Proc. Natl. Acad. Sci. USA, 98, 15044-15049.
16. Kretzschmar M, Doody J and Massague J. (1997). Nature, 389, 618-622.
17. Kretzschmar M, Doody J, Timokhina I and Massague J. (1999). Genes Dev., 13, 804-816.
18. Krohn K, Emmrich P, Ott N and Paschke R. (1999). Thyroid, 9, 241-246.
19. Libert F, Lefort A, Gerard C, Parmentier M, Perret J, Ludgate M, Dumont JE and Vassart G. (1989). Biochem. Biophys. Res. Commun., 165, 1250-1255.
20. Lopez-Casillas F, Wrana JL and Massague J. (1993). Cell, 73, 1435-1444.
21. Lutz M and Knaus P. (2002). Cell Signal., 14, 977.
22. Miyazono K. (1997). Int. J. Hematol., 65, 97-104.
23. Neumann S, Krause G, Chey S and Paschke R. (2001). Mol. Endocrinol., 15, 1294-1305.
24. Oda Y, Sanders J, Roberts S, Maruyama M, Kiddie A, Furmaniak J and Smith BR. (1999). J. Clin. Endocrinol. Metab., 84, 2119-2125.
25. Pang XP, Park M and Hershman JM. (1992). Endocrinology, 131, 45-50.
26. Park ES, Kim H, Suh JM, Park SJ, You SH, Chung HK, Lee KW, Kwon OY, Cho BY, Kim YK, Ro HK, Chung J and Shong M. (2000). Mol. Endocrinol., 14, 662-670.
27. Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, Dumont J and Vassart G. (1993). Nature, 365, 649-651.
28. Paschke R and Ludgate M. (1997). N. Engl. J. Med., 337, 1675-1681.
29. Ribeiro-Neto F, Urbani J, Lemee N, Lou L and Altschuler DL. (2002). Proc. Natl. Acad. Sci. USA, 99, 5418-5423.
30. Sandrock D, Olbricht T, Emrich D, Benker G and Reinwein D. (1993). Acta Endocrinol. (Copenh.), 128, 51-55.
31. Schoneberg T, Yun J, Wenkert D and Wess J. (1996). EMBO J., 15, 1283-1291.
32. Taton M, Lamy F, Roger PP and Dumont JE. (1993). Mol. Cell Endocrinol., 95, 13-21.
33. Trulzsch B, Krohn K, Wonerow P, Chey S, Holzapfel HP, Ackermann F, Fuhrer D and Paschke R. (2001). J. Mol. Med., 78, 684-691.
34. Trulzsch B, Krohn K, Wonerow P and Paschke R. (1999). Biotechniques, 27, 266-268.
35. Tsushima T, Arai M, Saji M, Ohba Y, Murakami H, Ohmura E, Sato K and Shizume K. (1988). Endocrinology, 123, 1187-1194.
36. Vanvooren V, Allgeier A, Nguyen M, Massart C, Parma J, Dumont JE and Van Sande J. (2001). Eur. J. Endocrinol., 144, 605-610.
37. Vicencio AG, Eickelberg O, Stankewich MC, Kashgarian M and Haddad GG. (2002). J. Appl. Physiol., 93, 1123-1130.
38. Voigt C, Holzapfel H and Paschke R. (2000). FEBS Lett., 486, 208-212.
39. Westfall PH and Young SS. (1993). Resampling-based Multiple Testing: Examples and Methods for Multiple P-value Adjustment. John Wiley & Sons: New York.
40. Wonerow P, Chey S, Fuhrer D, Holzapfel HP and Paschke R. (2000). Clin. Endocrinol. (Oxf.), 53, 461-468.
41. Wonerow P, Schoneberg T, Schultz G, Gudermann T and Paschke R. (1998). J. Biol. Chem., 273, 7900-7905.
42. Zhang K, Noda M, Vass WC, Papageorge AG and Lowy DR. (1990). Science, 249, 162-165.